Cargando…

Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes

BACKGROUND: This study aimed to investigate the patterns of use of antidiabetic medication among patients with newly diagnosed type 2 diabetes mellitus (T2DM), focusing on the comparison in glycemic control between sulfonylureas and metformin. MATERIAL/METHODS: Data from patients newly diagnosed and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yang, Yang, Zhirong, Lin, Hongbo, Shen, Peng, Wang, Haining, Zhan, Siyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287449/ https://www.ncbi.nlm.nih.gov/pubmed/30504761 http://dx.doi.org/10.12659/MSM.913603

Ejemplares similares

Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis
por: Sun, Feng, et al.
Publicado: (2012)

Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022)

Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
por: Zhao, Houyu, et al.
Publicado: (2023)

Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
por: Zhao, Houyu, et al.
Publicado: (2023)

Sulfonylurea and Cancer Risk Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
por: Zhao, Houyu, et al.
Publicado: (2022)

Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus
por: Luzuriaga, Maria, et al.
Publicado: (2021)

Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
por: Chai, Sanbao, et al.
Publicado: (2019)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China
por: Li, Hailong, et al.
Publicado: (2018)

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018
por: Engler, Clemens, et al.
Publicado: (2020)

Prescribing patterns of antidiabetics in type 2 diabetes and factors affecting them
por: Allyhiani, Moayad, et al.
Publicado: (2022)

Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents
por: Wang, Jing, et al.
Publicado: (2015)

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials
por: Yang, Jun, et al.
Publicado: (2017)

Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
por: Liu, Xiaojie, et al.
Publicado: (2017)

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
por: Dąbrowski, Mariusz
Publicado: (2021)

Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
por: Li, Zhixia, et al.
Publicado: (2016)

Does long-term use of antidiabetic drugs changes cancer risk?
por: Liu, Yi-Chun, et al.
Publicado: (2019)

Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study
por: Heissam, Khaled, et al.
Publicado: (2015)

Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study
por: Peng, Feng, et al.
Publicado: (2018)

Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2019)

Adherence to Antidiabetic Medications among Women with Gestational Diabetes
por: Asiedu-Danso, Michelle, et al.
Publicado: (2021)

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease
por: Wang, Guang, et al.
Publicado: (2008)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
por: Sun, Feng, et al.
Publicado: (2015)

Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study
por: Wang, Laicheng, et al.
Publicado: (2022)

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
por: Tres, Glaucia S., et al.
Publicado: (2018)

Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
por: DeCarlo, Kristen, et al.
Publicado: (2022)

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease
por: Pantalone, Kevin M., et al.
Publicado: (2018)

2156: A confounder assessment of patient frailty in the relationship between antidiabetic medication and heart failure
por: Presley, Caroline, et al.
Publicado: (2018)

Antidiabetic Effects of Tea
por: Fu, Qiu-Yue, et al.
Publicado: (2017)

Effect of number and type of antidiabetes medications on adherence and glycemia of ambulatory type 2 diabetes patients in southwestern Nigeria
por: Adisa, Rasaq, et al.
Publicado: (2013)

Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
por: Nguyen, Nam Nhat, et al.
Publicado: (2022)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2021)

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
por: Tajima, Atsushi, et al.
Publicado: (2022)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Nonglycemic Outcomes of Antidiabetic Medications
por: Morse, Christopher, et al.
Publicado: (2019)

Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy
por: Li, An-Chuan, et al.
Publicado: (2015)

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
por: Heo, Chan Uk, et al.
Publicado: (2019)

The Mechanism of Metabolic Influences on the Endogenous GLP-1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus
por: Nguyen, Thiquynhnga, et al.
Publicado: (2020)

Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tf02kr0gflaj49883mahp7rht